Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India

An open-label, non-inferiority, randomised controlled trial

From:
Foreign, Commonwealth & Development Office
Published
1 January 2011
Country:
India
Document Type:
Journal Article
Theme:
Health
Authors:
Sundar, S

Abstract

Improved treatment approaches are needed for visceral leishmaniasis. We assessed the efficacy and safety of three potential short-course combination treatments compared with the standard monotherapy in India.

Citation

Shyam Sundar et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet (2011) 377 (9764) 477-486 [doi:10.1016/S0140-6736(10)62050-8]

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial

Updates to this page

Published 1 January 2011
Contents